By Tod Hoffman, Lady Davis Institute for Medical Research

The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).

The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.

Classified as: CIHR, faculty of medicine, health, Cancer, jewish general hospital, Samy Suissa, diabetes, health and lifestyle, health canada, pancreatic cancer, CNODES, drug safety
Published on: 22 Feb 2016

The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report published online by JAMA Internal Medicine.

Classified as: Research, hypoglycemia, Laurent Azoulay, low blood sugar, McGill Jewsih General Hospiyal, opiod, pain-reliever, Samy Suissa, tramadol
Published on: 8 Dec 2014
Back to top